ici 200880 has been researched along with cephalosporin c in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davies, P; Dunlap, R; Krell, RD; Maycock, AL; Rennard, S; Stockley, RA; Turino, GM | 1 |
Davies, P; Dorn, C; Finke, P; Hanlon, WA; Humes, JL; Mumford, RA; Pacholok, SG | 1 |
2 other study(ies) available for ici 200880 and cephalosporin c
Article | Year |
---|---|
Selection of a therapeutic agent for the treatment of chronic obstructive pulmonary disease in smokers.
Topics: alpha 1-Antitrypsin; Biomarkers; Cephalosporins; Clinical Trials as Topic; Colchicine; Humans; Leukocyte Elastase; Lung Diseases, Obstructive; Oligopeptides; Pancreatic Elastase; Proteinase Inhibitory Proteins, Secretory; Proteins; Recombinant Proteins; Serine Proteinase Inhibitors; Smoking | 1991 |
Formation of polymorphonuclear leukocyte elastase: alpha 1 proteinase inhibitor complex and A alpha (1-21) fibrinopeptide in human blood stimulated with the calcium ionophore A23187. A model to characterize inhibitors of polymorphonuclear leukocyte elasta
Topics: alpha 1-Antitrypsin; Calcimycin; Cephalosporins; Chlorobenzoates; Dose-Response Relationship, Drug; Fibrin Fibrinogen Degradation Products; Humans; In Vitro Techniques; Leukocyte Elastase; Neutrophils; Oligopeptides; Pancreatic Elastase; Pyrrolidines | 1995 |